Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa

DOI Full Paper Access

11

Citations

2

References

2021

Year

Michela Iannone, Agata Janowska, Giulia Tonini, Giulia Davini, Valentina Dini

Clinics in Dermatology

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine EfficacyIxekizumab TreatmentCovid-19 VaccineImmunotherapyMedicineVaccine ResearchViral ImmunityHidradenitis SuppurativaCovid-19

References

	Year	Citations

Page 1

Page 1